Cerebral oedema

G6_CEROEDEMA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G93.6
  • Hospital discharge: ICD-9 3485
  • Cause of death: ICD-10 G93.6
  • Cause of death: ICD-9 3485

2 out of 7 registries used, show all original rules.

65

4. Check minimum number of events

None

65

5. Include endpoints

None

65

6. Filter based on genotype QC (FinnGen only)

65

Control definitions (FinnGen only)

Control exclude
G6_OTHNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G93
Name in latin
Oedema cerebri

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 918 430 478
Only index persons 515 232 283
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 50.49 52.34 48.62
Only index persons 51.71 52.78 50.83

-FinnGen-

Key figures

All Female Male
Number of individuals 65 31 34
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 54.83 54.33 55.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
61
Matched controls
610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.6
ICD-10 Finland
Cerebral oedema
+∞
82.2
59
*
N03AX14
ATC
levetiracetam; systemic
59.8
20.3
23
6
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
64.9
13.5
15
*
L01AX03
ATC
temozolomide; systemic
162.0
13.0
13
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
35.5
11.3
14
5
AA1AD
NOMESCO Finland
CT of head and brain
7.7
11.1
30
68
H02AB02
ATC
dexamethasone; systemic
10.1
10.2
21
30
130
Kela drug reimbursment
Malignant tumour
11.0
9.8
19
24
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
12.6
9.5
17
18
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
12.6
9.5
17
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
7.6
9.1
23
45
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
26.3
8.4
11
5
WX882
NOMESCO Finland
High dependency care
18.2
8.1
12
8
WX872
NOMESCO Finland
Intensive care
18.7
7.6
11
7
AAK00
NOMESCO Finland
Cranioplasty
+∞
7.4
7
*
AAK80
NOMESCO Finland
Partial excision of skull cap
+∞
7.4
7
*
R51.80
ICD-10 Finland
Headache
6.6
7.4
20
42
WF003
NOMESCO Finland
Adjuvant radiotherapy
34.5
7.4
9
*
N03AX18
ATC
lacosamide; systemic
45.2
6.9
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.6
6.8
21
52
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.9
6.7
15
24
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.3
6.6
18
38
ZXC95
NOMESCO Finland
Use of surgical navigator
30.1
6.4
8
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
6.3
6
*
AAF00
NOMESCO Finland
Ventriculostomy
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
5.0
6.1
21
58
WF002
NOMESCO Finland
Radical radiotherapy
17.2
6.1
9
6

Mortality – FinRegistry

Association

Association between endpoint G6_CEROEDEMA and mortality.

Females

Parameter HR [95% CI] p-value
G6_CEROEDEMA 9.279 [2.77, 31.05] < 0.001
Birth year 0.99 [0.98, 1.0] 0.032

During the follow-up period (1.1.1998 — 31.12.2019), 68 out of 166 females with G6_CEROEDEMA died.

Males

Parameter HR [95% CI] p-value
G6_CEROEDEMA 10.985 [5.1, 23.68] < 0.001
Birth year 0.989 [0.98, 1.0] 0.023

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 184 males with G6_CEROEDEMA died.

Mortality risk

Mortality risk for people of age

years, who have G6_CEROEDEMA.

N-year risk Females Males
1 0.852% 1.959%
5 4.155% 10.695%
10 11.262% 27.797%
15 21.457% 48.394%
20 33.987% 69.973%

Relationships between endpoints

Index endpoint: G6_CEROEDEMA – Cerebral oedema

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data